PUNIT DHILLON

Insider Reports History

Location
San Diego, CA
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PUNIT DHILLON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Chief Executive Officer, Director Common Stock 329,823 $1,645,817 $4.99 18 Nov 2024 Direct
Skye Bioscience, Inc. Chief Executive Officer, Director Common Stock 9,343 $46,622 $4.99 15 Nov 2024 Trust
Skye Bioscience, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 250,000 $11,050 $0.0170 24 Feb 2025 Direct
Arch Therapeutics, Inc. Director Stock Option (right to buy) 250,000 10 Nov 2022 Direct

Insider Reports Filed by PUNIT DHILLON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SKYE Skye Bioscience, Inc. 24 Feb 2025 1 $0 4 Chief Executive Officer, Director 26 Feb 2025, 17:43
SKYE Skye Bioscience, Inc. 15 Nov 2024 2 -$413,925 4 Chief Executive Officer, Director 19 Nov 2024, 21:20
SKYE Skye Bioscience, Inc. 28 Oct 2024 1 $0 4 Chief Executive Officer, Director 30 Oct 2024, 20:31
SKYE Skye Bioscience, Inc. 26 Aug 2024 1 $0 4 Chief Executive Officer, Director 27 Aug 2024, 17:20
SKYE Skye Bioscience, Inc. 29 Feb 2024 2 $0 4/A Chief Executive Officer, Director 04 Mar 2024, 06:13
SKYE Skye Bioscience, Inc. 29 Feb 2024 2 $0 4 Chief Executive Officer, Director 01 Mar 2024, 18:24
SKYE Skye Bioscience, Inc. 06 Nov 2023 2 $0 4 Chief Executive Officer, Director 06 Nov 2023, 20:29
SKYE Skye Bioscience, Inc. 25 Aug 2023 5 +$18,462 4/A Chief Executive Officer, Director 31 Aug 2023, 12:26
SKYE Skye Bioscience, Inc. 10 Nov 2022 6 $0 4 Chief Executive Officer, Director 15 Nov 2022, 12:41
ARTH Arch Therapeutics, Inc. 10 Nov 2022 1 $0 4 Director 10 Nov 2022, 20:54
SKYE Skye Bioscience, Inc. 14 Dec 2021 2 $0 4 Chief Executive Officer, Director 16 Dec 2021, 18:03
ARTH Arch Therapeutics, Inc. 27 Sep 2021 2 $0 4 Director 01 Oct 2021, 08:11